Brain tumor classification and segmentation for different weighted MRIs are among the most tedious tasks for many researchers due to the high variability of tumor tissues based on texture, structure, and position. Our study is divided into two stages: supervised machine learning-based tumor classification and image processing-based region of tumor extraction. For this job, seven methods have been used for texture feature generation. We have experimented with various state-of-the-art supervised machine learning classification algorithms such as support vector machines (SVMs), K-nearest neighbors (KNNs), binary decision trees (BDTs), random forest (RF), and ensemble methods. Then considering texture features into account, we have tried for fuzzy C-means (FCM), K-means, and hybrid image segmentation algorithms for our study. The experimental results achieved a classification accuracy of 94.25%, 87.88%, 89.57%, 96.99%, and 97% with SVM, KNN, BDT, RF, and Ensemble methods, respectively, on FLAIR-, T1C-, and T2-weighted MRI, and the hybrid segmentation attaining 90.16% mean dice score for tumor area segmentation against ground-truth images.
Brain tumor characterization (BTC) is the process of knowing the underlying cause of brain tumors and their characteristics through various approaches such as tumor segmentation, classification, detection, and risk analysis. The substantial brain tumor characterization includes the identification of the molecular signature of various useful genomes whose alteration causes the brain tumor. The radiomics approach uses the radiological image for disease characterization by extracting quantitative radiomics features in the artificial intelligence (AI) environment. However, when considering a higher level of disease characteristics such as genetic information and mutation status, the combined study of “radiomics and genomics” has been considered under the umbrella of “radiogenomics”. Furthermore, AI in a radiogenomics’ environment offers benefits/advantages such as the finalized outcome of personalized treatment and individualized medicine. The proposed study summarizes the brain tumor’s characterization in the prospect of an emerging field of research, i.e., radiomics and radiogenomics in an AI environment, with the help of statistical observation and risk-of-bias (RoB) analysis. The PRISMA search approach was used to find 121 relevant studies for the proposed review using IEEE, Google Scholar, PubMed, MDPI, and Scopus. Our findings indicate that both radiomics and radiogenomics have been successfully applied aggressively to several oncology applications with numerous advantages. Furthermore, under the AI paradigm, both the conventional and deep radiomics features have made an impact on the favorable outcomes of the radiogenomics approach of BTC. Furthermore, risk-of-bias (RoB) analysis offers a better understanding of the architectures with stronger benefits of AI by providing the bias involved in them.
Summary
Glioblastoma multiforme (GBM or glioblastoma) is a fast‐growing glioma that are the most invasive type of glial tumors, rapidly growing and commonly spreading into nearby brain tissue. Due to its aggressive and fast growing nature, patients suffer from high grade glioma (GBM) survive very less time as compare to other tumors. Prediction of patient survival (OS) time helps the radiologist for better systematic treatment planning and clinical decision making. The OS rate depends on the tumor size, shape, and different imaging features of brain. In this study, the OS period prediction was performed using Random Forest, SVM, XgBoost, and LGBM taking radiomic features which represents fused deep features and hand crafted features of the tumor. Efficiency of the prediction depends on the tumor volume that is segmented from the different MRI modalities. Hence the whole tumor and its sub tumor are extracted from multi‐modal MR images using U‐Net++ deep model and stacked together for deep features extraction using convolutional neural networks. To increase the accuracy, the features are reduced using PCA and then this radiomic feature set was used for OS period prediction. Prediction performance was evaluated for both 2‐class and 3‐class survival groups. The experiment was performed on well‐known dataset BraTS 2017 and achieved a classification AUC value as 63% for 3‐class classification and 2‐class group using different classifier. Segmentation DOR is computed as 1269.29, 2033.99, and 648.00 for complete tumor, enhancing tumor, and necrotic tumor extraction, respectively. To achieve even more accuracy, bio inspired optimization methods GA and PSO are used on fused feature set. Finally, the method achieves the AUC score of 0.66 using fused feature+SVM+GA (3‐class group) and 0.70 using fused feature+SVM+PSO (2‐class group) which outperforms the state‐of‐the‐art.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.